AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
PORTFOLIO-WIDE LEADERSHIP COMMITMENTS
98% GHG reduction by 2025
5% reduction in Energy Intensity by 2025
ASTRA ZENECA IS PARTICIPATING IN THE FOLLOWING DOE PROGRAMS:
|Better Climate Challenge||Better Plants Challenge|
|Low Carbon Pilot||Waste Reduction Network|
AstraZeneca received a 2018 Better Project Award for installing a 2.5 MW natural gas fired-combined heat and power system at its Gaithersburg, Maryland, facility, helping the site achieve 13.9% energy savings over the previous year.
NAICS 325, Chemical Manufacturing
Date of Pledge: October 2010
|GHG Emissions Goals|
|98%Reduction by 2025||Progress|
|Better Plants Energy Performance|
|5% Reduction in Energy Intensity||Progress|